We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Characteristics of people testing positive for COVID-19 from the Coronavirus (COVID-19) Infection Survey. This survey is being delivered in partnership with University of Oxford, University of Manchester, Public Health England and Wellcome Trust. This study is jointly led by the ONS and the...
Screening standards for the NHS newborn blood spot (NBS) screening programme.
S75 Screening relating to the Identity and Language (Northern Ireland) Bill.
Data reports, data collection templates and research application guidance for the NHS newborn blood spot (NBS) screening programme.
Data to support providers in improving cervical screening coverage and access to cervical screening services.
This provides details for screening providers on moving from printed leaflets to digital alternatives.
The NHS newborn hearing screening programme (NHSP) processes for ensuring a seamless and safe screening pathway.
Executive summary of the quality assurance (QA) visit to University Hospitals Birmingham NHS Foundation Trust ANNB screening programmes on 28 November 2019.
This protocol outlines the recommended process of primary screening for human papillomavirus (HPV).
Notifications of COVID-19 and influenza point-of-care testing (POCT) results: legal duties for providers of POCT.
This document describes the breast screening pathway.
Following this clinical pathway will help immunology services and teams to make sure babies are referred into diagnostic testing in the required timescales.
Executive summary of quality assurance (QA) visit to Nottingham University Hospitals antenatal and newborn screening programmes on 7 and 8 October 2019.
This publication covers all 6 inherited metabolic diseases (IMDs) and incorporates the previous PKU and MCADD laboratory handbooks.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).